COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
Background. Breast cancer is a heterogeneous disease with a variety of phenotypic forms. Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes characterized by high sensitivity to chemotherapy and early recurrence. Due to the lack of efficiency of standard therapeutic approache...
Saved in:
| Main Authors: | P. V. Krivorotko, E. K. Zhiltsova, L. P. Gigolaeva, Sh. M. Khadzhimatova, G. A. Dashyan, K. Yu. Zernov, E. S. Trufanova, А. S. Artemyeva, A. G. Kudaibergenova, V. F. Semiglazov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2017-12-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/558 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01) -
The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience
by: D. A. Enaldieva, et al.
Published: (2023-06-01) -
Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options
by: Yu. S. Sidorenko, et al.
Published: (2014-07-01) -
Current approaches to systemic treatment of <i>BRCA</i>-associated triple-negative breast cancer
by: D. A. Enaldieva, et al.
Published: (2023-10-01) -
NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
by: V. F. Semiglazov, et al.
Published: (2018-07-01)